Cullinan Therapeutics CGEM
NASDAQ CGEM
$14.53 -0.82 (-5.35%)
As of: Oct 1, 2026 · 3:59 PM EDT

Cullinan Therapeutics (CGEM) Long-Term Debt Issuances (2022)

Updated

Cullinan Therapeutics (CGEM) reported Long-Term Debt Issuances of $1.4 million for Q2 2022, up 75.0% from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Long-Term Debt Issuances (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 1.98 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Cullinan Therapeutics 987.71 Mn 987.71 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 1.40 Mn
Mar 31, 2022 800,000.00
API Access

Cullinan Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=CGEM&period=max&api_key=YOUR_API_KEY